Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction

Abstract Background The high incidence of recurrence and malignant transformation of colorectal adenoma (CRA) are current issues that need to be addressed in clinical practice. Canmei Formula (CMF) has shown promising results in the prevention and treatment, however, it lacks effective clinical data...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoling Fu, Yimin Xu, Xinyue Han, Xiangying Lin, Jingnan Wang, Guanhong Li, Xiaochen Fu, Min Zhang
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Biological Procedures Online
Subjects:
Online Access:https://doi.org/10.1186/s12575-025-00266-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571998785503232
author Xiaoling Fu
Yimin Xu
Xinyue Han
Xiangying Lin
Jingnan Wang
Guanhong Li
Xiaochen Fu
Min Zhang
author_facet Xiaoling Fu
Yimin Xu
Xinyue Han
Xiangying Lin
Jingnan Wang
Guanhong Li
Xiaochen Fu
Min Zhang
author_sort Xiaoling Fu
collection DOAJ
description Abstract Background The high incidence of recurrence and malignant transformation of colorectal adenoma (CRA) are current issues that need to be addressed in clinical practice. Canmei Formula (CMF) has shown promising results in the prevention and treatment, however, it lacks effective clinical data support and its mechanism of action is not fully elucidated. Objective The aim of this study is to evaluate the clinical efficacy and safety of CMF in preventing and treating CRA, and to explore its effective chemical components and pharmacological mechanisms. Method A randomized controlled clinical trial was conducted, with patients diagnosed with CRA within 6 months as the study subjects. After randomization, the patients were divided into a treatment group (receiving CMF granules) or a control group (receiving berberine hydrochloride tablets). The one-year recurrence rate of CRA was used as the key efficacy indicator to assess the effectiveness of CMF in preventing and treating CRA. The chemical components of CMF were identified using the UFLC-Q-TOF-MS/MS combined system. Data mining and the wSDTNBI algorithm were combined to construct a differential expression gene (DEG) - CMF prediction target interaction network for CRA. The core targets of CMF in CRA prevention and treatment were identified through topological analysis, and validated using molecular docking and in vitro experiments. Result During the period from October 1 2021 to December 31 2023, a total of 228 participants were included in the study. After block randomization, 114 patients were assigned to each group. In the treatment group, 98 patients completed follow-up examinations, with 16 patients (14.0%) exhibiting shedding, Adenoma recurrence was identified in 24 (24.5%) patients through colonoscopy. In the control group, 99 cases completed the follow-up examination, while 15 cases (13.2%) were lost to follow-up. There were 45 cases (45.5%) experienced recurrence of adenomas. During the follow-up period, no cases of colorectal cancer or severe adverse reactions were reported. UFLC-QTOF-MS/MS identification was combined with traditional Chinese medicine database mining to obtain 192 active chemical components of Canmei Formula. Using the wSDTNBI algorithm, 1044 prediction targets were predicted, and 3308 differentially expressed genes of CRA were extracted from the TCGA database. Network topology analysis and bioinformatics analysis were performed on 164 intersecting core targets. Molecular docking and qPCR analysis revealed that CMF downregulates angiotensin II type 1 receptor (AT1R) and regulated interleukin-8 (CXCL8) and matrix metalloproteinase 13 (MMP13) within the REN/Ang II/AT1R axis of the renin-angiotensin signaling pathway, thereby preventing and treating CRA. Conclusion This small-scale randomized controlled clinical trial showed that CMF granules can safely and effectively reduce the risk of CRA recurrence. CMF prevents and treats colorectal adenomas by modulating the renin-angiotensin signaling pathway and the inflammatory response.
format Article
id doaj-art-4f56694846bd441f98e278d81adba897
institution Kabale University
issn 1480-9222
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Biological Procedures Online
spelling doaj-art-4f56694846bd441f98e278d81adba8972025-02-02T12:08:54ZengBMCBiological Procedures Online1480-92222025-02-0127111610.1186/s12575-025-00266-5Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm PredictionXiaoling Fu0Yimin Xu1Xinyue Han2Xiangying Lin3Jingnan Wang4Guanhong Li5Xiaochen Fu6Min Zhang7Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineDepartment of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineDepartment of Hospital Affairs, Yueyang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese MedicineAbstract Background The high incidence of recurrence and malignant transformation of colorectal adenoma (CRA) are current issues that need to be addressed in clinical practice. Canmei Formula (CMF) has shown promising results in the prevention and treatment, however, it lacks effective clinical data support and its mechanism of action is not fully elucidated. Objective The aim of this study is to evaluate the clinical efficacy and safety of CMF in preventing and treating CRA, and to explore its effective chemical components and pharmacological mechanisms. Method A randomized controlled clinical trial was conducted, with patients diagnosed with CRA within 6 months as the study subjects. After randomization, the patients were divided into a treatment group (receiving CMF granules) or a control group (receiving berberine hydrochloride tablets). The one-year recurrence rate of CRA was used as the key efficacy indicator to assess the effectiveness of CMF in preventing and treating CRA. The chemical components of CMF were identified using the UFLC-Q-TOF-MS/MS combined system. Data mining and the wSDTNBI algorithm were combined to construct a differential expression gene (DEG) - CMF prediction target interaction network for CRA. The core targets of CMF in CRA prevention and treatment were identified through topological analysis, and validated using molecular docking and in vitro experiments. Result During the period from October 1 2021 to December 31 2023, a total of 228 participants were included in the study. After block randomization, 114 patients were assigned to each group. In the treatment group, 98 patients completed follow-up examinations, with 16 patients (14.0%) exhibiting shedding, Adenoma recurrence was identified in 24 (24.5%) patients through colonoscopy. In the control group, 99 cases completed the follow-up examination, while 15 cases (13.2%) were lost to follow-up. There were 45 cases (45.5%) experienced recurrence of adenomas. During the follow-up period, no cases of colorectal cancer or severe adverse reactions were reported. UFLC-QTOF-MS/MS identification was combined with traditional Chinese medicine database mining to obtain 192 active chemical components of Canmei Formula. Using the wSDTNBI algorithm, 1044 prediction targets were predicted, and 3308 differentially expressed genes of CRA were extracted from the TCGA database. Network topology analysis and bioinformatics analysis were performed on 164 intersecting core targets. Molecular docking and qPCR analysis revealed that CMF downregulates angiotensin II type 1 receptor (AT1R) and regulated interleukin-8 (CXCL8) and matrix metalloproteinase 13 (MMP13) within the REN/Ang II/AT1R axis of the renin-angiotensin signaling pathway, thereby preventing and treating CRA. Conclusion This small-scale randomized controlled clinical trial showed that CMF granules can safely and effectively reduce the risk of CRA recurrence. CMF prevents and treats colorectal adenomas by modulating the renin-angiotensin signaling pathway and the inflammatory response.https://doi.org/10.1186/s12575-025-00266-5Canmei FormulaColorectal adenoma recurrenceWSDTNBI algorithmRenin-angiotensin signaling pathway
spellingShingle Xiaoling Fu
Yimin Xu
Xinyue Han
Xiangying Lin
Jingnan Wang
Guanhong Li
Xiaochen Fu
Min Zhang
Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction
Biological Procedures Online
Canmei Formula
Colorectal adenoma recurrence
WSDTNBI algorithm
Renin-angiotensin signaling pathway
title Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction
title_full Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction
title_fullStr Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction
title_full_unstemmed Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction
title_short Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction
title_sort exploring the mechanism of canmei formula in preventing and treating recurrence of colorectal adenoma based on data mining and algorithm prediction
topic Canmei Formula
Colorectal adenoma recurrence
WSDTNBI algorithm
Renin-angiotensin signaling pathway
url https://doi.org/10.1186/s12575-025-00266-5
work_keys_str_mv AT xiaolingfu exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction
AT yiminxu exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction
AT xinyuehan exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction
AT xiangyinglin exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction
AT jingnanwang exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction
AT guanhongli exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction
AT xiaochenfu exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction
AT minzhang exploringthemechanismofcanmeiformulainpreventingandtreatingrecurrenceofcolorectaladenomabasedondataminingandalgorithmprediction